The iZafe group of today consists solely of the Healthcare segment, following the divestment of the Security segment in July 2020. The idea for the Healthcare segment was originally coined in 2008 as a means to ensure safe and proper dispensing of medicine to patients, which resulted in the digital medicine dispenser Dosell.
We believe that COVID-19 has created considerable tailwinds for the rollout of Dosell, as municipalities will increase the pace at which digital delivery methods for medicine are adopted. Furthermore, due to the scalability of the business model, a successful rollout of Dosell should provide strong profitability.
We see several current risks with iZafe Group. There is a financial risk, as the company is currently not profitable, and might have to rely on further external financing before it generates positive cash flows. Furthermore, the potential of Dosell is unknown and there are several competing digital medicine dispensers on the market.